Xueliang Wang1, Yunjiang Liu2, Kaixuan Zhou3, Geng Zhang3, Feifei Wang4, Jingwen Ren4. 1. Department of Dermatologic Surgery, The Fourth Hospital of Hebei Medical University Shijiazhuang 050011, Hebei, P. R. China. 2. Hebei Breast Disease Diagnosis and Treatment Center, The Fourth Hospital of Hebei Medical University Tianshan Road, Shijiazhuang 050035, Hebei, P. R. China. 3. Research Center, The Fourth Hospital of Hebei Medical University Shijiazhuang 050011, Hebei, P. R. China. 4. Clinical laboratory, The Fourth Hospital of Hebei Medical University Shijiazhuang 050011, Hebei, P. R. China.
Abstract
BACKGROUND: The epithelial-mesenchymal transition (EMT) generates cells with properties of stem cells, if that happened, the stem cell should be with mesenchymal property. This study aimed to identify a group of cells with mesenchymal stem cell (MSC)-like characteristics in breast cancer bone metastatic cell line MDA-MB-231, moreover, the relevance between breast cancer stem cells and the EMT was observed. CD105 and CD90, identified as the standards of MSCs, were used for the identification. METHODS: The CD105+/CD90+ and CD105-/CD90- subpopulation of MDA-MB-231 cells were detected and sorted by flow cytometry. MSC-like characteristics in cell proliferation, migration and cell cycle were investigated here by MTT asaay, transwell migration assay, and PI staining respectively. The expression profiles of some stem cell-associated genes were also observed by quantitative real time PCR. RESULTS: Around 0.99% and 90.77% of parental cells were identified as CD105+/CD90+ and CD105-/CD90- cell subpopulations respectively. The CD105+/CD90+ cells exhibited stronger migratory capacity as compared to parental and CD105-/CD90- cells, while less CD105+/CD90+ cells were arrested in the S phase. Besides, pluripotent stem cell factors, like Oct-4, Nanog, Klf4 and Sox-2, were all upregulated in CD105+/CD90+ cells, with also proliferation increase, as compared with other two populations. CONCLUSION: The CD105+/CD90+ subpopulation from breast cancer MDA-MB-231 cells was proven to possess "mesenchymal stem cell-like" characteristics, and its high migratory ability might be associated with EMT. Moreover, using the surface markers of CD105 and CD90 for the identification of MSCs might provide new theoretical basis for the recurrence and metastasis of breast cancer.
BACKGROUND: The epithelial-mesenchymal transition (EMT) generates cells with properties of stem cells, if that happened, the stem cell should be with mesenchymal property. This study aimed to identify a group of cells with mesenchymal stem cell (MSC)-like characteristics in breast cancer bone metastatic cell line MDA-MB-231, moreover, the relevance between breast cancer stem cells and the EMT was observed. CD105 and CD90, identified as the standards of MSCs, were used for the identification. METHODS: The CD105+/CD90+ and CD105-/CD90- subpopulation of MDA-MB-231 cells were detected and sorted by flow cytometry. MSC-like characteristics in cell proliferation, migration and cell cycle were investigated here by MTT asaay, transwell migration assay, and PI staining respectively. The expression profiles of some stem cell-associated genes were also observed by quantitative real time PCR. RESULTS: Around 0.99% and 90.77% of parental cells were identified as CD105+/CD90+ and CD105-/CD90- cell subpopulations respectively. The CD105+/CD90+ cells exhibited stronger migratory capacity as compared to parental and CD105-/CD90- cells, while less CD105+/CD90+ cells were arrested in the S phase. Besides, pluripotent stem cell factors, like Oct-4, Nanog, Klf4 and Sox-2, were all upregulated in CD105+/CD90+ cells, with also proliferation increase, as compared with other two populations. CONCLUSION: The CD105+/CD90+ subpopulation from breast cancer MDA-MB-231 cells was proven to possess "mesenchymal stem cell-like" characteristics, and its high migratory ability might be associated with EMT. Moreover, using the surface markers of CD105 and CD90 for the identification of MSCs might provide new theoretical basis for the recurrence and metastasis of breast cancer.
Entities:
Keywords:
Breast neoplasm; CD105; CD90; cancer stem cell; epithelial mesenchymal transition; mesenchymal stem cells
Authors: P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd Journal: J Natl Cancer Inst Date: 1990-07-04 Impact factor: 13.506
Authors: Ittai Ben-Porath; Matthew W Thomson; Vincent J Carey; Ruping Ge; George W Bell; Aviv Regev; Robert A Weinberg Journal: Nat Genet Date: 2008-05 Impact factor: 38.330
Authors: Kunal Mehta; Erika Moravcikova; David McFall; James D Luketich; Arjun Pennathur; Albert D Donnenberg; Vera S Donnenberg Journal: Ann Thorac Surg Date: 2017-05-09 Impact factor: 4.330
Authors: Aline Ramos Maia Lobba; Ana Claudia Oliveira Carreira; Otto Luiz Dutra Cerqueira; André Fujita; Carlos DeOcesano-Pereira; Cynthia Aparecida Bueno Osorio; Fernando Augusto Soares; Pranela Rameshwar; Mari Cleide Sogayar Journal: PLoS One Date: 2018-06-27 Impact factor: 3.240